PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsdyskinesias
MeSH D020820 - dyskinesias
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D009461:Neurologic manifestations
$
Success rate
D009069:Movement disorders
$
Success rate
D020820: 
Dyskinesias
D001259:Ataxia
0 Companies
0 Drugs
Success rate
D001264:Athetosis
0 Companies
0 Drugs
Success rate
D002375:Catalepsy
0 Companies
0 Drugs
Success rate
D002819:Chorea
$
Success rate
D004409:Drug-induced dyskinesia
$
Success rate
D004421:Dystonia
$
Success rate
D006948:Hyperkinesis
$
Success rate
D009207:Myoclonus
0 Companies
0 Drugs
Success rate
D011595:Psychomotor agitation
$
Success rate
D014202:Tremor
$
Success rate
D018476:Hypokinesia
0 Companies
0 Drugs
Success rate
0 Companies
0 Drugs
Success rate
D046608:Synkinesis
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
50%
1/2
Phase 2
24%
4/17
Phase 3
45%
5/11
Approved: 3Overall Success rate: 5%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
1
2
3
4
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use